Polymeric nanotherapeutics: clinical development and advances in stealth functionalization strategies.
about
Nanotheranostics - application and further development of nanomedicine strategies for advanced theranosticsEnzyme-responsive nanomaterials for controlled drug deliveryCell or cell membrane-based drug delivery systemsPolymer nanostructures synthesized by controlled living polymerization for tumor-targeted drug deliveryTherapeutic microparticles functionalized with biomimetic cardiac stem cell membranes and secretome.Clearance of pathological antibodies using biomimetic nanoparticles.Self-assembled Targeting of Cancer Cells by Iron(III)-doped, Silica NanoparticlesCurrent advances in polymer-based nanotheranostics for cancer treatment and diagnosisDesign and assembly of supramolecular dual-modality nanoprobesCell membrane-camouflaged nanoparticles for drug delivery.Biomaterials and emerging anticancer therapeutics: engineering the microenvironment.Safe and Immunocompatible Nanocarriers Cloaked in RBC Membranes for Drug Delivery to Treat Solid Tumors.The use of CD47-modified biomaterials to mitigate the immune response.Interfacial interactions between natural RBC membranes and synthetic polymeric nanoparticles.Cancer cell membrane-coated nanoparticles for anticancer vaccination and drug delivery.Coating nanoparticles with cell membranes for targeted drug delivery.Control of targeting ligand display by pH-responsive polymers on gold nanoparticles mediates selective entry into cancer cells.Antibody-targeted biodegradable nanoparticles for cancer therapy.Radiolabelled Polymeric Materials for Imaging and Treatment of Cancer: Quo Vadis?Erythrocytes in nanomedicine: an optimal blend of natural and synthetic materials.Biodegradable nanoparticles sequentially decorated with Polyethyleneimine and Hyaluronan for the targeted delivery of docetaxel to airway cancer cells.Surface functionalization of polymeric nanoparticles for tumor drug delivery: approaches and challenges.Hyaluronan-decorated polymer nanoparticles targeting the CD44 receptor for the combined photo/chemo-therapy of cancer.Polymers in the Co-delivery of siRNA and Anticancer Drugs for the Treatment of Drug-resistant Cancers.Biomimetic and bioinspired nanoparticles for targeted drug delivery.A Red Blood Cell Membrane-Camouflaged Nanoparticle Counteracts Streptolysin O-Mediated Virulence Phenotypes of Invasive Group A Streptococcus.Nano-sized cytochrome P450 3A4 inhibitors to block hepatic metabolism of docetaxel.Preparation and Application of Cell Membrane-Camouflaged Nanoparticles for Cancer Therapy.Biodegradable micelles capable of mannose-mediated targeted drug delivery to cancer cells.Nanoparticulate vacuolar ATPase blocker exhibits potent host-targeted antiviral activity against feline coronavirus.Nanotherapeutics for autoimmunity becomes mainstream.Erythrocyte-Platelet Hybrid Membrane Coating for Enhanced Nanoparticle Functionalization.Degradable polymeric nanoparticles by aggregation of thermoresponsive polymers and "click" chemistry.Evolution and Clinical Translation of Drug Delivery Nanomaterials.The Role of Hydrophobicity in the Cellular Uptake of Negatively Charged Macromolecules.Particle Targeting in Complex Biological Media.Effect of partial PEGylation on particle uptake by macrophages.Carboxyl group (-CO2 H) functionalized coordination polymer nanoparticles as efficient platforms for drug delivery.Concise Review: Is Cardiac Cell Therapy Dead? Embarrassing Trial Outcomes and New Directions for the Future.Biomimetic Targeting of Nanoparticles to Immune Cell Subsets via Cognate Antigen Interactions.
P2860
Q26860760-ECEB88EB-F676-4399-80A0-ADF3A821CA26Q26992127-7FC3E60C-72D8-4D9E-B0FE-A6EB02C78F36Q28080710-69AAC988-08AB-4211-8F4C-C79965A65248Q28085664-0162693E-BD33-4D02-B614-363BE01FEA87Q33908373-4B8B9BD8-13EE-411E-BCE6-6EE3FA1D00A7Q34218004-E68D271D-A7D6-49DD-A007-27263CF1147BQ34427093-8736184A-BAC9-4196-BF4B-DCD5728B35A1Q34783018-177E0AD3-FEE2-452D-AC95-2D79B03A4AB9Q36201042-55BA3786-41FE-4000-BCFA-E354712D1F8CQ36396004-8AA20402-C460-4B86-AA93-0EF966DF0A56Q36684345-67E7D313-595E-4413-B845-9B6F21ECB9CCQ36926013-D61AEE76-E47C-4E49-93B9-EFF2EF233475Q37107151-4B4A5F21-AFB1-46AA-83D5-A32FAED4FAABQ37638568-52708935-0B54-4AD1-9D7A-6206D3B4AEA9Q37701353-7F9EF16B-CA38-453F-B970-128722C02576Q38603358-0DD9E0A4-AF64-4EB2-8AEA-3B198D447ED9Q38660575-753B3A53-BD98-4738-BAB6-90EBDBD726A7Q38665261-CA8069DD-9EDA-4B1A-85D1-FD9BB3851861Q38755295-2F50F568-2BC0-4889-9073-C17110ED90DCQ38811159-D5565768-C97C-4B66-BC6A-CCD2038B68C0Q38885334-D639E45E-36BF-4DCE-B893-BF3B2A260D0EQ38899902-A6863DD3-AE57-4A60-8715-F5464045D859Q38913276-562FD5D7-63A2-407E-8DFE-C3FF97B8161DQ39125540-999444C2-FF31-4282-A546-74648D3C16B1Q39210548-F472F9E1-6E1F-4567-A84F-D2A69C6B4A6CQ40109133-A71ECE73-220C-4D3B-B723-EB3703D64B5BQ41283476-2FCB72B3-370E-4ED6-AD49-EEA9C09EBE4BQ41430285-BE754017-53E6-4B45-A6FF-974A22F27D38Q41529715-BA7607AB-B3EC-45DC-A7F6-B419C1F36873Q42376162-F77BBD3D-0697-4C58-89A4-2E8A412514FAQ42580233-7F26231C-6CC2-4453-8BF5-3569DC8D9446Q45983074-080DF8A7-EE2E-4965-AC25-670E36DDF462Q46665300-86A2931D-25DF-4344-9242-9E605C4E0C26Q47263594-206A5740-7052-4883-ADCD-81CCED626B7AQ47743746-F352CA11-C71F-444C-AC12-05A1FB6762CFQ47794249-59367F76-5AE1-4B49-825D-837CACFEB1BEQ48916206-DB63A7FF-FD9F-4371-B806-C295E38CD048Q50607684-351A73A7-FDED-4B41-A581-DA5C4F7A2B29Q52690932-63018E52-CA81-44C0-B9B0-D45CA1E5EAD9Q54256935-12A8D4CD-5A06-4685-97FF-8C7C3F32F6A6
P2860
Polymeric nanotherapeutics: clinical development and advances in stealth functionalization strategies.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年学术文章
@wuu
2013年学术文章
@zh-cn
2013年学术文章
@zh-hans
2013年学术文章
@zh-my
2013年学术文章
@zh-sg
2013年學術文章
@yue
2013年學術文章
@zh
2013年學術文章
@zh-hant
name
Polymeric nanotherapeutics: cl ...... functionalization strategies.
@en
type
label
Polymeric nanotherapeutics: cl ...... functionalization strategies.
@en
prefLabel
Polymeric nanotherapeutics: cl ...... functionalization strategies.
@en
P2093
P2860
P356
P1433
P1476
Polymeric nanotherapeutics: cl ...... functionalization strategies.
@en
P2093
Brian T Luk
Che-Ming J Hu
Liangfang Zhang
Ronnie H Fang
P2860
P356
10.1039/C3NR05444F
P407
P577
2013-11-26T00:00:00Z